Project Updates

WuXi AppTec's API Manufacturing Plant, Taixing, China.

Location: Taixing, China
Project type: API manufacturing facility
Acres: 169 acres
Construction started: Started April 2021

WuXi STA, a US-based contract research, development, and manufacturing company and subsidiary of WuXi AppTec, opened an active pharmaceutical ingredient (API) manufacturing facility at the Taixing site in Jiangsu, China, in January 2024.

Novo Nordisk Foundation Cellerator.

Location: Lyngby, Denmark
Project type: Cell therapy manufacturing facility
Expected construction start: Mid-2024
Estimated Investment: DKr950m

The Novo Nordisk Foundation, the philanthropic arm of pharmaceutical company Novo Nordisk, is developing a new advanced laboratory facility named Novo Nordisk Foundation Cellerator in Lyngby, Denmark, for the development and manufacture of cell therapies.

Credit: VGXI

Location: Conroe, Texas, US
Project type: Headquarters and biomanufacturing facility
Start of Construction: November 2020
Area: 120,000ft²

VGXI, a wholly-owned manufacturing subsidiary of GeneOne Life Science, opened its new headquarters and greenfield biomanufacturing facility at Deison Technology Park in Conroe, Texas.